About DeVoro Medical
DeVoro Medical is a company based in Fremont (United States) founded in 2018 by Michael P Wallace was acquired by Boston Scientific in September 2021.. DeVoro Medical has raised $18 million across 1 funding round from investors including Boston Scientific. DeVoro Medical offers products and services including WOLF Thrombectomy Platform, EkoSonic Endovascular System, and AngioJet Thrombectomy System. DeVoro Medical operates in a competitive market with competitors including Tactile Medical, Intervene, enVVeno Medical, Sky Medical Technology and Veniti, among others.
- Headquarter Fremont, United States
- Founders Michael P Wallace
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Boston Scientific Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18 M (USD)
in 1 rounds
-
Latest Funding Round
$18 M (USD), Series B
Jul 02, 2020
- Investors
-
Employee Count
Employee Count
-
Acquired by
Boston Scientific
(Sep 21, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DeVoro Medical
DeVoro Medical offers a comprehensive portfolio of products and services, including WOLF Thrombectomy Platform, EkoSonic Endovascular System, and AngioJet Thrombectomy System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Removes blood clots in arterial and venous systems
Treats thromboemboli with ultrasound technology
Clears clots in blood vessels efficiently
Unlock access to complete
Unlock access to complete
Software Development Team
298 people
Leadership Team
132 people
Senior Team
105 people
Sales and Marketing
103 people
Product Management Team
65 people
Human Resources and Administration
40 people
Principal Team
37 people
Clinical Team
27 people
Unlock access to complete
Funding Insights of DeVoro Medical
DeVoro Medical has successfully raised a total of $18M through 1 strategic funding round. The most recent funding activity was a Series B round of $18 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $18.0M
-
First Round
First Round
(02 Jul 2020)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Series B - DeVoro Medical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DeVoro Medical
DeVoro Medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boston Scientific. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wide range of medical devices
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DeVoro Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DeVoro Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Devoro Medical Comparisons
Competitors of DeVoro Medical
DeVoro Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tactile Medical, Intervene, enVVeno Medical, Sky Medical Technology and Veniti, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Home therapy devices for lymphedema and venous ulcers are provided.
|
|
| domain | founded_year | HQ Location |
Catheter-based therapy for chronic venous insufficiency is developed.
|
|
| domain | founded_year | HQ Location |
Developer of medical device for the the treatment of venous diseases
|
|
| domain | founded_year | HQ Location |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| domain | founded_year | HQ Location |
A self-expanding stent system for chronic venous disease is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about DeVoro Medical
When was DeVoro Medical founded?
DeVoro Medical was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is DeVoro Medical located?
DeVoro Medical is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Who is the current CEO of DeVoro Medical?
Michael P Wallace is the current CEO of DeVoro Medical. They have also founded this company.
Is DeVoro Medical a funded company?
DeVoro Medical is a funded company, having raised a total of $18M across 1 funding round to date. The company's 1st funding round was a Series B of $18M, raised on Jul 02, 2020.
What does DeVoro Medical do?
DeVoro Medical was founded in 2018 and is located in Fremont, United States. Medical devices targeted at cardiac disease treatment are developed by the company within the healthcare sector. Operations center on smart products for the peripheral thrombectomy area, utilizing a novel flow restoration technology. Blood flow in affected body regions is restored through these devices, supporting clinical interventions in cardiovascular care.
Who are the top competitors of DeVoro Medical?
DeVoro Medical's top competitors include Tactile Medical, Intervene and enVVeno Medical.
What products or services does DeVoro Medical offer?
DeVoro Medical offers WOLF Thrombectomy Platform, EkoSonic Endovascular System, and AngioJet Thrombectomy System.
Who are DeVoro Medical's investors?
DeVoro Medical has 1 investor. Key investors include Boston Scientific.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.